Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

Abstract Title:

Curcumin attenuates rapamycin-induced cell injury of vascular endothelial cells.

Abstract Source:

J Cardiovasc Pharmacol. 2015 Jul 7. Epub 2015 Jul 7. PMID: 26167809

Abstract Author(s):

Ning Guo, Fangyuan Chen, Juan Zhou, Yuan Fang, Hongbing Li, Yongbai Luo, Yong Zhang

Article Affiliation:

Ning Guo

Abstract:

Although drug-eluting stents (DES) effectively improve the clinical efficacy of percutaneous coronary intervention, a high risk of late stent thrombosis and in-stent restenosis also exists after DES implantation. Anti-smooth muscle proliferation drugs, such as rapamycin, coating stents not only inhibit the growth of vascular smooth muscle cells but also inhibit vascular endothelial cells and delay the re-endothelialization. Therefore, the development of an ideal agent that protects vascular endothelial cells from rapamycin-eluting stents is of great importance for the next-generation of DES. In the present study, we demonstrated that rapamycin significantly inhibited the growth of rat aortic endothelial cells (RAECs) in both a dose- and time-dependent manner in vitro. Cell apoptosis was increased and migration was decreased by rapamycin treatments in RAECs in vitro. Surprisingly, treatment with curcumin, an active ingredient of turmeric, significantly reversed these detrimental effects of rapamycin. Moreover, curcumin increased the expression of vascular nitric oxide synthases (eNOS) which was decreased by rapamycin. Furthermore, caveolin-1, the inhibitor of eNOS, was decreased by curcumin. Knockdown of eNOS by small interfering RNA significantly abrogated the protective effects of curcumin. Taken together, our results suggest that curcumin antagonizes the detrimental effect of rapamycin on aortic endothelial cells in vitro through up-regulating eNOS. Therefore, curcumin is a promising combined agent for the rescue of DES-induced re-endothelialization delay.

Study Type : In Vitro Study

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.